From the Chair
An expert editorial series from Nephrology Times
Ajay Singh discusses the state of rare kidney disease research.
Dr. Ajay Singh and others pay tribute to Dr. Barry Brenner, a leading nephrologist who passed away in August 2024.
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.
Ajay Singh pays tribute to the late nephrologist and researcher Nicolaos Madias, MD, of Tufts Medical Center.
The four-pillar approach to treating diabetic kidney disease (DKD) has been endorsed by high-quality trials, such as FLOW.
IgA nephropathy (IgAN) is on the cusp of a transformational change in its treatment.
APRIL has emerged as a critical factor in the pathogenesis of IgAN and is the focus of several clinical development programs.
The benefit-risk ratio and considerations about unmet need are worth considering.
SGLT2i therapy is contraindicated in patients with type 1 diabetes mellitus (T1DM) who have CKD.
The first part of the dialysis moonshot is to prevent the need for dialysis.
Measuring eGFR and UACR is a key component of guideline-directed medical therapy for patients with CKD from type 2 diabetes.
The most important patients who should receive treatment with SGLT2 inhibitors are those with CKD and type 2 diabetes.
Sodium-glucose transport protein 2 (SGLT2) inhibitors (SGLT2i), or gliflozins, block SGLT2 cotransporters in the ...
From the Chair
...
From the Chair
...
Managing blood pressure is probably the most important intervention that a nephrologist pursues in slowing kidney ...
Approximately 221 million people worldwide have been diagnosed with infection from SARS-CoV-2, the virus that causes ...
The approval by the US FDA on August 23, 2021, of difelikefalin (marketed as Korsuva™ by Cara Therapeutics) is a major ...
In a thought-provoking Viewpoint article in JAMA Surgery1, Arthur Matas, MD, makes the case for introducing a regulated ...
Editor's Note:
...
In the July/August 2019 issue of Nephrology Times1 I published an article on the idea of a dialysis moonshot, based on ...
COVID-19 is essentially an acute respiratory illness that in some patients, especially vulnerable groups, can be fatal. ...
In a point-counterpoint-editorial contribution in the January 1 issue of Kidney International, Richard Glassock and ...
Nearly one-half of patients >75 years of age who initiate dialysis are dead within 6 months (almost one-half are dead ...
Advertisement
Knowledge Hubs
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.